GNMK - GenMark Diagnostics EPS misses by $0.04 beats on revenue

GenMark Diagnostics (GNMK): Q4 GAAP EPS of -$0.05 misses by $0.04.Revenue of $50.08M (+84.1% Y/Y) beats by $1.03M.ePlex® revenue of $45.4M, an increase of 138% Y/Y.Gross margin of 39%, compared to 34% Y/Y.Average annuity per analyzer of $220,000, compared to $148,000 Y/Y.2021 Guidance: Revenue of $188-$198M, which represents growth of 10%-15% Y/Y; Global ePlex placements from 200-220 net new analyzers with annuity/analyzer between $175K and $190K; Gross margin of 44%- 46% and operating expenses to be ~$85-$90M.Shares -1.6%.Press Release

For further details see:

GenMark Diagnostics EPS misses by $0.04, beats on revenue